Your browser doesn't support javascript.
loading
Clinical efficacy of mTOR inhibitors in solid tumors: a systematic review.
Huang, Zebo; Wu, Yinxia; Zhou, Xin; Qian, Jiaqi; Zhu, Wei; Shu, Yongqian; Liu, Ping.
Affiliation
  • Huang Z; 1Department of Oncology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, People's Republic of China.
  • Wu Y; 2Department of Oncology, Clinical Medical College of Yangzhou University, No 98 Nantong Western Road, Yangzhou 225001, People's Republic of China.
  • Zhou X; 1Department of Oncology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, People's Republic of China.
  • Qian J; 1Department of Oncology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, People's Republic of China.
  • Zhu W; 1Department of Oncology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, People's Republic of China.
  • Shu Y; 1Department of Oncology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, People's Republic of China.
  • Liu P; 1Department of Oncology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, People's Republic of China.
Future Oncol ; 11(11): 1687-99, 2015.
Article in En | MEDLINE | ID: mdl-26043220

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Protein Kinase Inhibitors / TOR Serine-Threonine Kinases / Neoplasms Type of study: Systematic_reviews Limits: Humans Language: En Journal: Future Oncol Year: 2015 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Protein Kinase Inhibitors / TOR Serine-Threonine Kinases / Neoplasms Type of study: Systematic_reviews Limits: Humans Language: En Journal: Future Oncol Year: 2015 Type: Article